The specificity of the MIG-15/JNK-1 pathway compared to the DLK-1/PMK-3 and MLK-1/KGB-1 pathways in worms suggests inhibitors of specific JNK isoforms could have differing efficacy in neurodegenerative disease models. The gene discussed is MAP3K9; the disease is neurodegenerative disease.